Skip to main content

Ophthalmology and Visual Sciences Archives

Glaucoma study finds brain fights to preserve vision

Feb. 22, 2018—A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.

Read more


Sternberg named president-elect of ophthalmology association

Feb. 22, 2018—Paul Sternberg Jr., MD, George Weeks Hale Professor and chair of Ophthalmology and Visual Sciences at Vanderbilt, was recently named president-elect of the Association of University Professors of Ophthalmology (AUPO).

Read more


Ophthalmologists’ opioid prescribing patterns studied

Nov. 9, 2017—Prescription opioid abuse is at epidemic levels, and Vanderbilt University Medical Center’s Shriji Patel, M.D., assistant professor of Ophthalmology and Visual Sciences, wanted to find out what part, if any, his colleagues play in the crisis.

Read more


Study seeks new ways to detect sensory issues in TBI patients

Oct. 26, 2017—Vanderbilt researcher Tonia Rex, Ph.D., is accustomed to performing studies in her lab with a goal of translating the findings into better diagnoses and treatment tools for the visually impaired.

Read more


Novel procedure eases vision loss from keratoconus

Aug. 24, 2017—Uyen Tran, M.D., has performed hundreds of corneal transplants for her patients at Vanderbilt University Medical Center (VUMC).

Read more


Award honors Donahue’s long-term efforts to improve children’s vision

Aug. 17, 2017—Sean Donahue, M.D., Ph.D., Sam and Darthea Coleman Professor of Pediatric Ophthalmology at Vanderbilt, recently received the Bonnie Strickland Champion for Children’s Vision Award.

Read more


Keep an eye on safety during upcoming solar eclipse

Jul. 26, 2017—On Aug. 21 millions of people will look skyward as day turns into night when the first coast-to-coast solar eclipse in nearly a century passes over Middle Tennessee.

Read more


Cytokine linked to blindness

Jun. 30, 2017—A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

Read more


Memorial service for Professor Vivien Casagrande set for April 12

Mar. 24, 2017—A memorial service for Professor Vivien Casagrande is planned for April 12 in Benton Chapel.

Read more


Grant strengthens Brantley’s vision research efforts

Feb. 16, 2017—Milam Brantley Jr., M.D., Ph.D., associate professor of Ophthalmology and Visual Sciences and Molecular Physiology and Biophysics, recently received a $500,000 grant from the Edward N. and Della L. Thome Memorial Foundation Awards Program in Macular Degeneration Research to further his work on age-related macular degeneration (AMD).

Read more


Symposium honors Casagrande’s career

Dec. 1, 2016—Colleagues of Vivien Casagrande, Ph.D., celebrated her distinguished career in the visual sciences with a “Lifetime of Vision” symposium Nov. 18 in Biological Sciences/Medical Research Building III.

Read more


Vanderbilt ophthalmologist emphasizes care in dim-light driving as time change brings darkness to evening commute

Nov. 3, 2016—With the end of daylight saving time, ophthalmologists at the Vanderbilt Eye Institute want to focus on a real issue—dim-light driving situations that can endanger drivers and pedestrians.

Read more


Page 1 of 512345